2019
DOI: 10.6060/mhc190662m
|View full text |Cite
|
Sign up to set email alerts
|

2,6-Dibrominated 3,5-DistyrylBODIPYs as Photosensitizer Dyes for Photodynamic Antimicrobial Chemotherapy

Abstract: A 2,6-dibrominated BODIPY core dye with a meso-pyrenyl group has been investigated for use as a photosensitizer dye in photodynamic antimicrobial chemotherapy in the context of both gram-positive (Staphylococcus aureus) and gramnegative (Escherichia coli) bacteria, along with a π-extended 3,5-di-4-carboxystyrylBODIPY dye. The dyes are found to be effective for the treatment of S. aureus, but not in the case of E. coli.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 56 publications
0
1
0
Order By: Relevance
“…The photophysicochemical properties of 1 – 4 have been analyzed in CHCl 3 , ethanol, THF, DMSO and their photodynamic antimicrobial activities (PACT) were examined against Staphylococcus aureus ( S. aureus ) as a representative gram‐(+) bacteria. Although brominated 3,5‐distyrylBODIPY dyes have previously been reported for PACT studies (18–20), to the best of our knowledge, this is the first example of a diiodinated diarylvinylBODIPY derivative in this context.…”
Section: Introductionmentioning
confidence: 93%
“…The photophysicochemical properties of 1 – 4 have been analyzed in CHCl 3 , ethanol, THF, DMSO and their photodynamic antimicrobial activities (PACT) were examined against Staphylococcus aureus ( S. aureus ) as a representative gram‐(+) bacteria. Although brominated 3,5‐distyrylBODIPY dyes have previously been reported for PACT studies (18–20), to the best of our knowledge, this is the first example of a diiodinated diarylvinylBODIPY derivative in this context.…”
Section: Introductionmentioning
confidence: 93%